Skip to main content
Top
Published in: Clinical and Translational Oncology 5/2013

01-05-2013 | Erratum

Erratum to: Polymorphisms in HIF-1alpha affect presence of lymph node metastasis and can influence tumor size in squamous-cell carcinoma of the glottic larynx

Authors: F. Mera-Menéndez, A. Hinojar-Gutiérrez, M. Guijarro Rojas, J. García de Gregorio, E. Mera-Menéndez, J. J. Sánchez, M. Quintanilla, L. Cerezo, C. Gamallo

Published in: Clinical and Translational Oncology | Issue 5/2013

Login to get access

Excerpt

In the original published article, the category and sub-category are given wrong. …
Metadata
Title
Erratum to: Polymorphisms in HIF-1alpha affect presence of lymph node metastasis and can influence tumor size in squamous-cell carcinoma of the glottic larynx
Authors
F. Mera-Menéndez
A. Hinojar-Gutiérrez
M. Guijarro Rojas
J. García de Gregorio
E. Mera-Menéndez
J. J. Sánchez
M. Quintanilla
L. Cerezo
C. Gamallo
Publication date
01-05-2013
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 5/2013
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-012-0944-6

Other articles of this Issue 5/2013

Clinical and Translational Oncology 5/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine